84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]周勇,徐祖健,柴天朋,等.非創(chuàng)傷性股骨頭壞死骨髓水腫與磁共振分期的關(guān)系及骨髓水腫發(fā)生機(jī)制的初步研究[J].中醫(yī)正骨,2016,28(08):8-12.
 ZHOU Yong,XU Zujian,CHAI Tianpeng,et al.A pilot study on relationship between bone marrow edema and magnetic resonance staging and pathogenesy of bone marrow edema in patients with non-traumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):8-12.
點(diǎn)擊復(fù)制

非創(chuàng)傷性股骨頭壞死骨髓水腫與磁共振分期的關(guān)系及骨髓水腫發(fā)生機(jī)制的初步研究()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期數(shù):
2016年08期
頁(yè)碼:
8-12
欄目:
臨床研究
出版日期:
2016-08-20

文章信息/Info

Title:
A pilot study on relationship between bone marrow edema and magnetic resonance staging and pathogenesy of bone marrow edema in patients with non-traumatic osteonecrosis of femoral head
作者:
周勇1徐祖健2柴天朋3任菲菲1楊茂清1雷孝勇2
1.四川省成都市雙流區(qū)中醫(yī)醫(yī)院,四川 成都 610200; 2.西南醫(yī)科大學(xué)附屬中醫(yī)醫(yī)院, 四川 瀘州 646000; 3.四川省新津縣中醫(yī)醫(yī)院,四川 新津 611400
Author(s):
ZHOU Yong1XU Zujian2CHAI Tianpeng3REN Feifei1YANG Maoqing1LEI XIaoyong2
1.Shuangliu Hospital of Traditional Chinese Medicine,Chengdu 610200,Sichuan,China 2.The TCM Hospital Affiliated to Southwest Medical University,Luzhou 646000,Sichuan,China 3.Xinjin Hospital of Traditional Chinese Medicine,Xinjin 611400,Sichuan,China
關(guān)鍵詞:
股骨頭壞死 骨髓 水腫 血管內(nèi)皮生長(zhǎng)因子類 骨形態(tài)發(fā)生蛋白2 免疫組織化學(xué)
Keywords:
femur head necrosis bone marrow edema vascular endothelial growth factors bone morphogenetic protein 2 immunohistochemistry
摘要:
目的:初步探討非創(chuàng)傷性股骨頭壞死(non-traumatic osteonecrosis of femoral head,NONFH)骨髓水腫與磁共振分期的關(guān)系及骨髓水腫的發(fā)生機(jī)制。方法:分析40例接受單側(cè)人工髖關(guān)節(jié)置換術(shù)的NONFH患者的術(shù)前髖關(guān)節(jié)磁共振影像,對(duì)比不同的股骨頭壞死國(guó)際骨循環(huán)研究會(huì)(association research circulation osseous,ARCO)分期時(shí)骨髓水腫的發(fā)生情況,并根據(jù)有無(wú)骨髓水腫將40例患者分為2組。將從單側(cè)人工髖關(guān)節(jié)置換術(shù)中取得的40個(gè)股骨頭沿冠狀面自正中用擺鋸剖開(kāi),在交界區(qū)鑿取1塊約1.0 cm×1.0 cm×0.4 cm的骨塊,制成石蠟切片,采用免疫組織化學(xué)法測(cè)定血管內(nèi)皮生長(zhǎng)因子(vascular endothelial growth factor,VEGF)和骨形態(tài)發(fā)生蛋白2(bone morphogenetic protein 2,BMP-2)的表達(dá)情況,并做組間對(duì)比。結(jié)果:①不同ARCO分期骨髓水腫的發(fā)生情況。ARCOⅢ期骨髓水腫25例、無(wú)骨髓水腫4例,ARCOⅣ期骨髓水腫3例、無(wú)骨髓水腫8例,ARCOⅢ期骨髓水腫發(fā)生率高于ARCOⅣ期(χ2=10.533,P=0.000); ARCOⅢ期輕度骨髓水腫3例、重度骨髓水腫22例,ARCOⅣ期輕度骨髓水腫1例、重度骨髓水腫2例,ARCOⅢ期骨髓水腫嚴(yán)重程度與ARCOⅣ期比較,差異無(wú)統(tǒng)計(jì)學(xué)意義(P=0.382)。②VEGF和BMP-2的表達(dá)情況。骨髓水腫組VEGF和BMP-2的陽(yáng)性面積百分比均高于無(wú)骨髓水腫組[(21.04±3.87)%,(15.25±3.36)%,t=4.490,P=0.000;(19.04±4.56)%,(13.67±2.77)%,t=3.780,P=0.001],VEGF和BMP-2的平均灰度均低于無(wú)骨髓水腫組[29.93±4.26,36.33±2.96,t=4.730,P=0.000; 39.43±4.59,45.50±2.94,t=4.210,P=0.001]。結(jié)論:NONFH骨髓水腫易發(fā)生于ARCOⅢ期,其發(fā)生與VEGF和BMP-2的表達(dá)有關(guān)。骨髓水腫可能是NONFH病變過(guò)程中的一種繼發(fā)反應(yīng)和局部組織自我修復(fù)增強(qiáng)的表現(xiàn),但仍需今后進(jìn)一步研究證實(shí)。
Abstract:
Objective:To explore the relationship between bone marrow edema(BME)and magnetic resonance(MR)staging and the pathogenesy of BME in patients with non-traumatic osteonecrosis of femoral head(NONFH).Methods:The preoperative hip magnetic resonance images(MRI)of 40 patients who received unilateral artificial hip replacement for treatment of NONFH were analyzed,and the incidence rate of BME were compared between different clinical stages of femur head necrosis issued by association research circulation osseous(ARCO).The patients were divided into BME group and non-BME group.Forty necrotic femoral heads that achieved via unilateral artificial hip replacements were splited along the median coronal plane by using swing saw,and a 1.0×1.0×0.4-cm specimen was fetched from the junctional zone of each femoral head and was made into paraffin sections.Then the expressions of vascular endothelial growth factor(VEGF)and bone morphogenetic protein 2(BMP-2)were detected by using immunohistochemical method and were compared between the 2 groups.Results:Twenty-five patients with BME and 4 patients without BME were categorized as ARCO phaseⅢ,while 3 patients with BME and 8 patients without BME were categorized as ARCO phaseⅣ.The incidence rate of BME was higher in ARCO phaseⅢ compared to ARCO phaseⅣ(χ2=10.533,P=0.000).Mild BME(3)and severe BME(22)were found in ARCO phaseⅢwhile mild BME(1)and severe BME(2)were found in ARCO phaseⅣ,and there was no statistical difference in severity of BME between ARCO phaseⅢ and phaseⅣ(P=0.382).The positive area percentages of VEGF and BMP-2 were higher in BME group compared to non-BME group(21.04+/-3.87 vs 15.25+/-3.36%,t=4.490,P=0.000; 19.04+/-4.56 vs 13.67+/-2.77%,t=3.780,P=0.001),and the average gray values of VEGF and BMP-2 were lower in BME group compared to non-BME group(29.93+/-4.26 vs 36.33+/-2.96,t=4.730,P=0.000; 39.43+/-4.59,45.50+/-2.94,t=4.210,P=0.001).Conclusion:BME occurs more frequently in ARCO phaseⅢin patients with NONFH and its occurence may be related to the expression of VEGF and BMP-2.BME may be a secondary response and manifestations of self-repair enhancement in local tissues in the pathological process of NONFH.However,further study is needed to verify the deduction in the future.

參考文獻(xiàn)/References:

[1] 中華醫(yī)學(xué)會(huì)骨科分會(huì)顯微修復(fù)學(xué)組,中國(guó)修復(fù)重建外科專業(yè)委員會(huì)骨缺損及骨壞死學(xué)組.成人股骨頭壞死診療標(biāo)準(zhǔn)專家共識(shí)(2012年版)[J].中華骨科雜志,2012,32(6):606-610. [2] Mont MA,Etienne G,Ragland PS.Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head[J].Clin Orthop Relat Res,2003,(417):84-92. [3] Fuchs B,Knothe U,Hertel R,et al.Femoral osteotomy and iliac graft vascularization for femoral head osteonecrosis[J].Clin Orthop Relat Res,2003,412(412):84-93. [4] 張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(3):20-23. [5] 姚運(yùn)峰,康鵬德,呂浩,等.鉆孔減壓植骨和股方肌骨瓣植入治療早期成人股骨頭壞死的療效比較[J].中國(guó)骨與關(guān)節(jié)損傷雜志,2014,29(12):1193-1195. [6] 周勇,豐凡翔,斯光宴,等.介入聯(lián)合中藥保髖治療非創(chuàng)傷性股骨頭壞死的研究[J].瀘州醫(yī)學(xué)院學(xué)報(bào),2014,37(4):407-410. [7] 何偉,陳鎮(zhèn)秋,張慶文.補(bǔ)腎活血中藥治療股骨頭壞死臨床研究[J].新中醫(yī),2012,44(4):50-51. [8] 曹利敏,方琴,顧惠珍,等.高壓氧治療股骨頭壞死的療效觀察[J].中國(guó)現(xiàn)代醫(yī)生,2013,51(8):141-142. [9] Gardeniers JW.ARCO intronational stage of osteonecrosis[J].ARCO Newsletter,1993,5: 79-82. [10] 趙培榮,莊奇新,喬瑞華,等.股骨頭缺血壞死骨髓水腫的MRI研究[J].實(shí)用放射學(xué)雜志,2006,22(7):835-837. [11] 陳軍,瞿玉興.骨髓水腫的現(xiàn)代研究[J].長(zhǎng)春中醫(yī)藥大學(xué)學(xué)報(bào),2010,26(2):255-256. [12] Koo KH,Ahn IO,Song HR,et al.Increased perfusion of the femoral head in transient bone marrow edema syndrome[J].Clin Orthop Relat Res,2002,402(402):171-175. [13] Battaglia Parodi M,Iacono P,Verbraak FD,et al.Antivascular endothelial growth factors for inflammatory chorioretinal disorders[J].Dev Ophthalmol,2010,46:84-95. [14] Hiltunen MO,Ruuskanen M,Huuskonen J,et al.Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo[J].FASEB J,2003,17(9):1147-1149. [15] 許心弦,溫宏,呂楊訓(xùn),等.信號(hào)傳導(dǎo)及轉(zhuǎn)錄激活因子1誘導(dǎo)骨細(xì)胞凋亡在激素性股骨頭壞死過(guò)程中的作用[J].中醫(yī)正骨,2014,26(2):3-7. [16] 李敏,吳俊華,吳曉惠,等.伴骨髓水腫的膝骨關(guān)節(jié)炎與血管內(nèi)皮因子、缺氧誘導(dǎo)因子1α的相關(guān)性研究[J].中華臨床醫(yī)師雜志(電子版),2015,9(20):3696-3699. [17] 周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(8):7-10.

相似文獻(xiàn)/References:

[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型 血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
 XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2 在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
 ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[4]鮑榮華,王國(guó)平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
 ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂(lè)郭氏正骨方藥藥物組成 最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
 LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療 ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
 ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):14.
[9]鮑榮華,王國(guó)平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
 ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):20.

備注/Memo

備注/Memo:
基金項(xiàng)目:四川省衛(wèi)生廳科研項(xiàng)目(100238) 通訊作者:徐祖健 E-mail:[email protected]
更新日期/Last Update: 1900-01-01